Since its inception more than 50 years ago, BrightFocus and its flagship research programsAlzheimers Disease Research, Macular Degeneration Research, and National Glaucoma Researchhas awarded more than $330 million in research grants to scientists around the world, catalyzing thousands of scientific breakthroughs, life-enhancing treatments, and diagnostic tools
The future directions and challenges of new small-molecule GLP-1R agonists, such as danuglipron, are multifaceted
H., Goff D
A Medical Providers Guide to the Mitochondrial Peptide for Metabolism, Energy, and Longevity MOTS-c is a 16-amino-acid peptide encoded in your mitochondrial DNA, and it has become one of the fastest-growing peptide therapies in metabolic and longevity medicine
Xanthine-oxidase inhibitors and statins in chronic heart failure: effects on vascular and functional parameters
Effects of a MAO-B Inhibitor in the Treatment of Alzheimer Disease